Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xiaoyuan,Chen

第一单位： School of Medicine, Southeast University, Nanjing, China.

作者： Xiaoyuan,Chen ^[1] ; Yiwei,Lu ^[2] ; Xiaoli,Shi ^[3] ; Xuejiao,Chen ^[4] ; Dawei,Rong ^[2] ; Guoyong,Han ^[3] ; Long,Zhang ^[4] ; Chuangye,Ni ^[1] ; Jie,Zhao ^[2] ; Yun,Gao ^[3] ; Xuehao,Wang ^[4]

作者单位： School of Medicine, Southeast University, Nanjing, China. ^[1] Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. ^[2] Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, Nanjing, China. ^[3] NHC Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), Nanjing, China. ^[4] Department of General Surgery, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China. ^[5]

DOI 10.1155/2021/3002480

PMID 34925507

发布时间 2022-04-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of oncology

2021年2021卷

3002480页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma.

Journal of oncology

相似文献

Journal of oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma.

Journal of oncology

相似文献

Journal of oncology

相关期刊

检索历史清除